Improving cervical cancer screening for women with HIV
Part of Cancer, Immune system & allergy, Infections, Women’s health & pregnancy clinical trials.
This study aims to make cervical cancer screening easier and more accessible for women living with HIV. Researchers will test new ways to help women get screened and receive follow-up care at three clinics across the United States.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman living with HIV who receives care at one of the participating clinics
- You are between ages 25 and 49
- You are eligible for cervical cancer screening according to U.S. national guidelines
- You still have your cervix (have not had a hysterectomy)
- You are willing to participate in cervical cancer screening
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests different ways to screen for HPV (a virus linked to cervical cancer) in women living with HIV. The goal is to find the best, most practical screening approach to catch cervical problems early.
This trial offers quick cervical cancer screening and treatment for women living with HIV, aiming to prevent cancer and improve health.
This trial tests a new way to prevent cervical cancer in women with both HIV and HPV. It focuses on women in India who are already on stable HIV treatment and have a normal cervical exam.
This trial tests two cervical screening approaches to find early signs of HPV-related changes. It may help by improving how results are sorted into “needs follow-up” versus “routine care,” especially for women with different HPV patterns.
This trial tests a program to screen and treat HIV-positive women for cervical cancer in La Romana, Dominican Republic. It may help catch and manage cervical cancer early.
This study looks at HPV infection and the natural balance of bacteria in the vagina in women with HIV. It aims to understand how these factors affect health and may guide future prevention or treatment.
Hear when a new Human Papillomavirus (HPV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.